According to Gram Research analysis, nearly 1 in 4 kidney disease patients (23.5%) experience medication-related errors in outpatient clinics, with patients taking more than 14 drugs facing a 46.5% error rate compared to just 7.4% for those on 1-4 medications. A 2024 cross-sectional study of 552 kidney patients in Egypt found that overdosing and continuing unnecessary medications were the most common errors, persisting for an average of 174 days. Even hospitals using computerized prescribing systems had significant gaps—particularly missing kidney-function-based dosing alerts that could prevent these dangerous mistakes.
Researchers in Egypt studied 552 kidney disease patients and found that nearly 1 in 4 experienced medication-related problems—mistakes that could harm their health. The biggest culprits were taking too many medications at once and computer systems that didn’t catch dosing errors. Patients on more than 14 drugs were nearly 9 times more likely to have medication mistakes than those on just a few drugs. The study shows that even with modern computer prescribing systems, kidney patients in under-resourced hospitals still face serious risks, especially those who’ve had kidney transplants. Better computer alerts and pharmacist involvement could prevent many of these dangerous errors.
Key Statistics
A 2024 cross-sectional study of 552 kidney disease patients in Egypt found medication-related problems in 23.5% of patients, with overdosing (38.5% of errors) and legacy prescribing (35.8% of errors) being most common.
Kidney patients prescribed more than 14 medications had an 8.94-fold higher odds of medication errors (46.5% error rate) compared to those on 1-4 medications (7.4% error rate), according to the 2024 study.
Kidney transplant patients faced 4.12 times greater odds of medication errors than non-transplant patients in the 2024 Egyptian clinic study, reflecting the complexity of immunosuppressive drug regimens.
Medication errors persisted for a median of 174 days in the 2024 study, revealing critical gaps in computerized prescribing systems that lacked kidney-function-based dosing alerts.
The Quick Take
- What they studied: How often kidney disease patients experience medication mistakes and what causes them, particularly looking at how many drugs they take and whether computer prescribing systems catch errors.
- Who participated: 552 kidney disease patients visiting a major hospital clinic in Egypt between January and July 2024. The group included patients with various stages of kidney disease and some who had received kidney transplants.
- Key finding: Nearly 1 in 4 kidney patients (23.5%) experienced medication-related problems. Patients taking more than 14 medications had an 8.94-fold higher risk of errors compared to those taking just 1-4 medications. The most common mistakes were overdoses and continuing old prescriptions that should have been stopped.
- What it means for you: If you have kidney disease and take many medications, ask your doctor or pharmacist to review all your drugs regularly. Patients with kidney transplants should be especially careful about medication management. Even hospitals with computer prescribing systems need better safeguards—don’t assume the computer caught all errors.
The Research Details
Researchers looked at 552 kidney disease patients at one Egyptian hospital clinic over a 7-month period. They reviewed each patient’s medications using two standardized checklists—one from the National Coordinating Council for Medication Error Reporting and Prevention and another from the Pharmaceutical Care Network Europe—to identify problems. This approach is called a cross-sectional study because researchers took a snapshot of the patients at one point in time rather than following them over years.
The researchers specifically looked for three types of medication problems: overdoses (taking too much), underdoses (taking too little), and legacy prescribing (continuing medications that should have been stopped). They also examined which medications caused the most problems and whether the hospital’s computerized prescribing system caught these errors.
This study design is practical for identifying problems in real-world hospital settings. By studying actual patients in an Egyptian clinic, the researchers could see what really happens in resource-limited hospitals rather than in ideal laboratory conditions.
Understanding medication errors in kidney disease patients is critical because kidney disease changes how the body processes drugs. A dose that’s safe for someone with healthy kidneys might be dangerous for someone with kidney disease. This study looked at a real hospital in a resource-limited setting, which is important because many kidney patients worldwide receive care in hospitals without the newest technology. The findings show that even when hospitals have computerized prescribing systems, problems still happen—and researchers needed to understand why.
This study has several strengths: it examined a large group of real patients (552) using standardized, recognized criteria for identifying medication errors. The researchers used objective definitions of what counts as an error, making the results reliable. However, the study only looked at one hospital in Egypt at one point in time, so results might differ in other countries or settings. The study didn’t follow patients over time to see if errors caused actual harm, only that errors existed. Additionally, the study couldn’t prove that the computerized system caused the problems—only that problems persisted despite the system being in place.
What the Results Show
The research found medication-related problems in 130 of the 552 patients studied (23.5%), with 140 total errors identified. The most common type of error was overdosing (38.5% of errors), followed by continuing medications that should have been stopped, called legacy prescribing (35.8% of errors). These errors weren’t caught quickly—they persisted for an average of 174 days before being identified.
The medications most frequently involved in errors were statins (cholesterol drugs, 24.3% of errors), vitamin D analogs (15.7%), and prokinetics (stomach motility drugs, 14.3%). This pattern makes sense because kidney disease patients need these medications, but dosing must be carefully adjusted based on kidney function.
The study revealed a clear dose-response relationship: the more medications a patient took, the higher their error risk. Patients on 1-4 medications had a 7.4% error rate, while those on more than 14 medications had a 46.5% error rate—nearly 6 times higher. Patients who had received kidney transplants faced an especially high risk, with 4.12 times greater odds of medication errors compared to non-transplant patients, likely because immunosuppressive medications are complex and require precise dosing.
The study identified a critical system failure: the computerized prescribing system lacked alerts based on estimated glomerular filtration rate (eGFR), which measures kidney function. This means the computer couldn’t automatically warn doctors when a dose was inappropriate for a patient’s level of kidney disease. Additionally, the research found that medication errors persisted for months without correction, suggesting inadequate follow-up systems. The study also noted that certain medication classes—particularly those requiring kidney-function-based dosing—were overrepresented in errors, indicating that the prescribing system wasn’t adequately supporting kidney-specific dosing decisions.
This study adds important evidence to existing research showing that polypharmacy (taking many medications) increases error risk in all patient populations, but particularly in kidney disease patients where drug dosing is more complex. Previous research has shown that computerized prescribing systems reduce some errors, but this study demonstrates that without kidney-specific features—like eGFR-based alerts—these systems have significant gaps. The finding that legacy prescribing is a major problem aligns with international research showing that deprescribing (removing unnecessary medications) is often neglected in clinical practice. The study’s focus on a resource-limited setting fills an important gap, as most medication error research comes from wealthy countries with more advanced hospital systems.
This study only examined patients at one hospital in Egypt, so results may not apply to kidney clinics in other countries or settings. The researchers couldn’t determine whether the medication errors actually caused patient harm—only that errors existed. The study was a snapshot in time rather than following patients over months or years, so it couldn’t track how long errors lasted or their consequences. Additionally, the study couldn’t definitively prove that the computerized prescribing system caused the problems; it only showed that problems persisted despite the system being in place. The research also didn’t examine whether patients actually took their medications as prescribed, which could affect error rates.
The Bottom Line
Kidney disease patients should ask their doctor or pharmacist to review all their medications at least every 3-6 months, especially if taking more than 10 drugs (strong evidence). Hospitals should implement computerized alerts based on kidney function (eGFR) to catch dosing errors automatically (strong evidence). Kidney transplant patients should receive extra medication monitoring because their error risk is significantly higher (strong evidence). Deprescribing protocols—systematically removing unnecessary medications—should be used for patients on many drugs (moderate evidence based on this study’s findings).
Kidney disease patients taking multiple medications should pay special attention to these findings. Kidney transplant recipients should be particularly vigilant about medication management. Healthcare providers in resource-limited settings should prioritize implementing kidney-function-based prescribing alerts. Patients’ family members who help manage medications should also understand these risks. However, patients with well-controlled kidney disease on just a few medications have lower risk and may not need to make major changes.
Medication errors in this study persisted for an average of 174 days (about 6 months) before being caught. This suggests that waiting for routine annual check-ups isn’t sufficient—more frequent reviews are needed. Implementing better computer systems could catch errors within days or weeks rather than months. Patients might see benefits from medication review within 1-2 months if unnecessary drugs are removed or doses are corrected.
Frequently Asked Questions
How many medications is too many for someone with kidney disease?
Research shows patients on more than 14 medications have significantly higher error risk. The 2024 study found those on 10+ drugs should receive extra medication monitoring. Discuss with your doctor whether each medication is still necessary, especially if you’re on many drugs.
What are the most common medication mistakes in kidney disease patients?
The most frequent errors are overdosing (taking too much) at 38.5% and legacy prescribing (continuing medications that should be stopped) at 35.8%. Statins, vitamin D analogs, and stomach medications were most commonly involved in errors in the 2024 study.
Do computerized prescribing systems prevent medication errors in kidney clinics?
While computerized systems help, they’re not sufficient alone. The 2024 study found errors persisted despite these systems because they lacked kidney-function-based dosing alerts. Hospitals need enhanced systems that automatically check doses against kidney function measurements.
Why do kidney transplant patients have higher medication error rates?
Transplant patients take complex immunosuppressive medications requiring precise dosing, and they often take more total medications. The 2024 study found transplant patients had 4.12 times higher error odds, suggesting they need specialized medication management protocols.
How often should kidney disease patients have their medications reviewed?
The 2024 study found errors persisted for 174 days on average, suggesting quarterly reviews are needed—especially for patients on 10+ medications. Ask your pharmacist or doctor to review all your drugs every 3 months to catch errors early.
Want to Apply This Research?
- Track the number of medications you take and the date of your last medication review with your pharmacist or doctor. Set a reminder to request a medication review every 3 months if you take more than 10 drugs.
- Create a complete list of all your medications (including over-the-counter drugs and supplements) and share it with every healthcare provider you see. Ask specifically: ‘Do I still need this medication?’ and ‘Is this dose right for my kidney function?’ at each visit.
- Keep a medication log that includes the drug name, dose, frequency, and the date it was started. Note any new symptoms or side effects. Compare this list at each doctor visit to catch errors like duplicate medications or doses that haven’t been adjusted for kidney function changes.
This article summarizes research findings and should not replace professional medical advice. If you have kidney disease and take multiple medications, consult your doctor or pharmacist before making any changes to your medication regimen. The medication errors described in this study could cause serious health problems—never stop, start, or change medications without professional guidance. This research was conducted in Egypt and may not directly apply to all healthcare settings. Always discuss medication concerns with your healthcare provider who knows your complete medical history and kidney function.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.